Fishy Whales
Security

BMY · Bristol Myers Squibb Co

0 institutional holder(s) · 40 congressional trade(s)
← Funds
Bristol Myers Squibb develops drugs in oncology, hematology, and immunology, including Opdivo and Eliquis. Patent expirations have made its pipeline a key investor focus. It is traded by 17 members of Congress in disclosed filings.

Institutional holders

13F
FundValueShares
No tracked fund holds “BMY”.

Congressional trades

STOCK Act
MemberTypeDate
Ro Khanna buy 04/13/2026
Ro Khanna buy 02/05/2026
Ro Khanna sell 01/29/2026
Ro Khanna buy 01/23/2026
Julie Johnson sell 12/18/2025
Julie Johnson sell 11/13/2025
Julie Johnson sell 08/14/2025
Jefferson Shreve sell 05/12/2025
Julia Letlow sell 04/28/2025
Tommy Tuberville sell 04/15/2025
Julie Johnson buy 01/15/2025
Julia Letlow buy 10/23/2024
Tommy Tuberville buy 04/03/2024
Tommy Tuberville sell 04/03/2024
Rick Larsen sell 01/09/2024
Tommy Tuberville sell 01/03/2024
Tommy Tuberville sell 11/16/2023
Greg Stanton sell 10/24/2023
Tommy Tuberville buy 10/17/2023
Greg Stanton buy 09/26/2023
Dan Sullivan sell 08/22/2023
Dan Goldman sell 07/12/2023
Shelley Capito sell 05/10/2023
Dan Goldman buy 04/10/2023
Dan Sullivan sell 01/10/2023
Nicholas Van Taylor sell 11/28/2022
Addison McDowell buy 07/15/2022
Shelley Capito sell 06/17/2022
Thomas R Carper buy 01/18/2022
Thomas Suozzi sell 06/07/2021
Thomas Suozzi sell 06/04/2021
Carol Miller buy 03/04/2021
Rick Larsen buy 11/25/2020
Thomas Suozzi sell 07/30/2020
Thomas Suozzi sell 07/10/2020
Thomas Suozzi sell 06/03/2020
Thomas Suozzi sell 01/09/2020
Thomas Suozzi sell 03/29/2019
Thomas Suozzi buy 04/17/2018
Alan S. Lowenthal sell 09/25/2017